DIVA Laboratories Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	549.14	494.03	589.14	536.93	346.37	299.28
Cash & Short-Term Investments	549.14	494.03	589.14	536.93	346.37	299.28
Cash Growth	-14.54%	-16.14%	9.72%	55.02%	15.73%	-8.67%
Accounts Receivable	311.6	285.5	262.41	203.13	281.89	190.37
Other Receivables	27.33	22.94	23.45	10.08	19.55	13.31
Receivables	338.93	308.44	285.86	213.2	301.44	203.68
Inventory	306.57	249.82	151.42	196.21	319.3	352.32
Prepaid Expenses	4.32	27.27	3.88	4.86	8.42	11.5
Other Current Assets	1.6	4.81	0.75	5.21	0.86	7.8
Total Current Assets	1,201	1,084	1,031	956.41	976.39	874.57
Property, Plant & Equipment	214.42	217.38	222.96	231.46	225.57	227.56
Long-Term Investments	6.33	7.58	5.03	4.61	6.32	30.94
Goodwill	-	-	-	-	-	5.18
Other Intangible Assets	0.92	1	1.71	0.74	1.31	4.41
Long-Term Deferred Tax Assets	37.79	37.72	40.76	47.33	38.27	36.08
Other Long-Term Assets	5.92	5.64	3.92	3.19	3.94	2.94
Total Assets	1,466	1,354	1,305	1,244	1,252	1,182
Accounts Payable	93.89	77.47	70.69	61.07	85.15	103.88
Accrued Expenses	-	73.95	74.97	65.11	67.2	45.6
Current Portion of Leases	1.35	2.59	2.47	2.53	0.13	0.13
Current Income Taxes Payable	24.78	24.44	23.32	22.02	24.35	5.75
Current Unearned Revenue	7.53	8.19	6.51	9.11	8.81	6.2
Other Current Liabilities	369.91	136.81	68.95	43.47	48.95	30.72
Total Current Liabilities	497.46	323.45	246.92	203.31	234.59	192.27
Long-Term Leases	0.26	0.31	2.5	4.97	0.15	0.28
Pension & Post-Retirement Benefits	-	-	-	0.19	0.87	2.69
Long-Term Deferred Tax Liabilities	0.98	0.76	0.43	0.87	-	0.02
Other Long-Term Liabilities	-	-	0.1	1.59	-	-
Total Liabilities	498.7	324.52	249.94	210.93	235.62	195.27
Common Stock	586.68	586.68	600.91	600.91	617.59	617.59
Additional Paid-In Capital	287.1	347.14	382.33	393.58	400	400
Retained Earnings	100.45	101.61	124.06	92.02	107.76	78.75
Treasury Stock	-	-	-45.99	-45.99	-99.91	-99.91
Comprehensive Income & Other	-7	-6.27	-5.8	-7.72	-9.26	-10
Total Common Equity	967.23	1,029	1,056	1,033	1,016	986.42
Shareholders' Equity	967.23	1,029	1,056	1,033	1,016	986.42
Total Liabilities & Equity	1,466	1,354	1,305	1,244	1,252	1,182
Total Debt	1.61	2.9	4.97	7.51	0.28	0.41
Net Cash (Debt)	547.53	491.13	584.17	529.42	346.08	298.86
Net Cash Growth	-14.23%	-15.93%	10.34%	52.98%	15.80%	-8.64%
Net Cash Per Share	9.28	8.33	9.91	8.99	5.88	5.08
Filing Date Shares Outstanding	59.16	58.67	58.67	58.67	58.67	58.67
Total Common Shares Outstanding	59.16	58.67	58.67	58.67	58.67	58.67
Working Capital	703.09	760.92	784.13	753.1	741.8	682.3
Book Value Per Share	16.35	17.54	17.99	17.60	17.32	16.81
Tangible Book Value	966.31	1,028	1,054	1,032	1,015	976.83
Tangible Book Value Per Share	16.33	17.53	17.96	17.59	17.30	16.65
Land	-	154.92	154.92	154.92	154.92	154.92
Buildings	-	85.42	85.42	85.42	85.42	85.42
Machinery	-	75.47	91.36	90.79	86.84	84.46